FibroGen, Inc. (0IL8.L)

USD 0.25

(-14.21%)

Total Assets Summary of FibroGen, Inc.

  • FibroGen, Inc.'s latest annual total assets in 2023 was 423.52 Million USD , down -30.58% from previous year.
  • FibroGen, Inc.'s latest quarterly total assets in 2024 Q1 was 365.86 Million USD , down -13.61% from previous quarter.
  • FibroGen, Inc. reported annual total assets of 610.08 Million USD in 2022, down -21.16% from previous year.
  • FibroGen, Inc. reported annual total assets of 773.82 Million USD in 2021, down -6.41% from previous year.
  • FibroGen, Inc. reported quarterly total assets of 365.86 Million USD for 2024 Q1, down -13.61% from previous quarter.
  • FibroGen, Inc. reported quarterly total assets of 515.12 Million USD for 2023 Q2, down -4.35% from previous quarter.

Annual Total Assets Chart of FibroGen, Inc. (2023 - 2012)

Historical Annual Total Assets of FibroGen, Inc. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 423.52 Million USD -30.58%
2022 610.08 Million USD -21.16%
2021 773.82 Million USD -6.41%
2020 826.84 Million USD -3.56%
2019 857.39 Million USD -2.63%
2018 880.59 Million USD -2.01%
2017 898.65 Million USD 91.38%
2016 469.55 Million USD -0.22%
2015 470.57 Million USD -2.68%
2014 483.52 Million USD 62.83%
2013 296.95 Million USD 11.81%
2012 265.58 Million USD 0.0%

Peer Total Assets Comparison of FibroGen, Inc.

Name Total Assets Total Assets Difference
uniQure N.V. 831.68 Million USD 49.076%
Agios Pharmaceuticals, Inc. 937.11 Million USD 54.805%
Amicus Therapeutics, Inc. 777.88 Million USD 45.553%
Atara Biotherapeutics, Inc. 165.5 Million USD -155.903%
bluebird bio, Inc. 619.16 Million USD 31.596%
Cara Therapeutics, Inc. 125.84 Million USD -236.551%
Imunon, Inc. 21.91 Million USD -1832.328%
Editas Medicine, Inc. 499.15 Million USD 15.15%
IQVIA Holdings Inc. 26.68 Billion USD 98.413%
Mettler-Toledo International Inc. 3.35 Billion USD 87.378%
Myriad Genetics, Inc. 1.19 Billion USD 64.668%
Neurocrine Biosciences, Inc. 3.25 Billion USD 86.974%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 69.941%
Verastem, Inc. 149.71 Million USD -182.884%
Walgreens Boots Alliance, Inc. 81.03 Billion USD 99.477%
Waters Corporation 4.62 Billion USD 90.846%
Thermo Fisher Scientific Inc. 98.72 Billion USD 99.571%
Biogen Inc. 26.84 Billion USD 98.422%
Nektar Therapeutics 398.03 Million USD -6.405%
Perrigo Company plc 10.8 Billion USD 96.082%
Dynavax Technologies Corporation 997.09 Million USD 57.524%
Illumina, Inc. 10.11 Billion USD 95.811%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD -1398.03%
Iovance Biotherapeutics, Inc. 780.35 Million USD 45.726%
Heron Therapeutics, Inc. 222.5 Million USD -90.345%
Unity Biotechnology, Inc. 65.69 Million USD -544.739%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 93.81%
Sangamo Therapeutics, Inc. 165.32 Million USD -156.187%
Evolus, Inc. 188.99 Million USD -124.092%
Adicet Bio, Inc. 207.29 Million USD -104.312%
Aclaris Therapeutics, Inc. 197.4 Million USD -114.548%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 98.72%
Esperion Therapeutics, Inc. 205.79 Million USD -105.8%
Agilent Technologies, Inc. 10.76 Billion USD 96.065%
OPKO Health, Inc. 2.01 Billion USD 78.947%
Homology Medicines, Inc. 47.05 Million USD -800.034%
Geron Corporation 394.07 Million USD -7.474%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 88.941%
Exelixis, Inc. 2.94 Billion USD 85.606%
Viking Therapeutics, Inc. 368.49 Million USD -14.936%
Anavex Life Sciences Corp. 154.38 Million USD -174.331%
Intellia Therapeutics, Inc. 1.3 Billion USD 67.445%
Zoetis Inc. 14.28 Billion USD 97.035%
Axsome Therapeutics, Inc. 588.23 Million USD 28.0%
Abeona Therapeutics Inc. 64 Million USD -561.743%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 98.137%
Kala Pharmaceuticals, Inc. 55.94 Million USD -656.991%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 85.835%
Sarepta Therapeutics, Inc. 3.26 Billion USD 87.027%
Corcept Therapeutics Incorporated 621.51 Million USD 31.856%
Halozyme Therapeutics, Inc. 1.73 Billion USD 75.565%
Blueprint Medicines Corporation 1.04 Billion USD 59.635%
Insmed Incorporated 1.32 Billion USD 68.152%
TG Therapeutics, Inc. 329.58 Million USD -28.503%
Incyte Corporation 6.78 Billion USD 93.755%
Emergent BioSolutions Inc. 1.83 Billion USD 76.918%